Skip to main content
Friulchem logo

Friulchem — Investor Relations & Filings

Ticker · FCM ISIN · IT0005378457 LEI · 8156003DC8C04217A094 XMIL Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2021-04-23 AGM Information
Country IT Italy
Listing XMIL FCM

About Friulchem

https://www.friulchem.com/en/homepage-2/

Friulchem is a Contract Development and Manufacturing Organization (CDMO) dedicated to the Animal Health sector. The company provides integrated services that cover the research, development, and production of veterinary products. Its manufacturing capabilities include micronization, granulation, mixing, spray drying, and packaging. Friulchem produces a range of items, including pharmaceuticals, food supplements, complementary feeds, and premixes for both livestock and companion animals. The company utilizes proprietary drug delivery technologies to develop customized formulations. A key product is Fc-Cubes®, a highly palatable chewable tablet for pets, which is part of its Suppleo brand of complementary foods.

Recent filings

Filing Released Lang Actions
Assemblea ordinaria e straordinaria degli azionisti di Friulchem
AGM Information Classification · 99% confidence The document is a press release dated April 23, 2021, detailing the resolutions passed during the Ordinary and Extraordinary Shareholders' Meeting ('L'ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI'). Key actions include the approval of the Financial Statements for the year ended December 31, 2020, the appointment of the auditor for 2021-2023, and the approval of amendments to the bylaws. Since the document explicitly reports the results of shareholder voting on resolutions, including the approval of the annual financial statements and the appointment of auditors, it strongly aligns with the purpose of an Annual General Meeting (AGM) event. The classification 'AGM-R' (AGM Information) is the most appropriate fit for materials summarizing the outcomes of such a meeting.
2021-04-23 Italian
Avviso convocazione Assemblea 29 aprile 2021
AGM Information Classification · 99% confidence The document is titled "Convocazione Assemblea Ordinaria e Straordinaria" (Notice of Ordinary and Extraordinary Shareholders' Meeting) for FRIULCHEM S.p.A. It details the date, time, and specific agenda items (Ordine del giorno) for the meeting, including approval of the 2020 financial statements (Parte Ordinaria) and amendments to the bylaws (Parte Straordinaria). It also extensively covers the procedures for shareholder participation, voting via a Designated Representative (Rappresentante Designato) due to COVID-19 measures, and deadlines for submitting proposals. This content is characteristic of a formal notice calling shareholders to a meeting, which aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2021-04-08 Italian
FRIULCHEM: APPROVATO IL PROGETTO DI BILANCIO AL 31 DICEMBRE 2020
Earnings Release Classification · 95% confidence The document is explicitly titled "COMUNICATO STAMPA" (Press Release) and announces that the Board of Directors of Friulchem S.p.A. has approved the Draft Financial Statements ("Progetto di Bilancio") as of December 31, 2020. It provides key financial highlights (Revenue, EBITDA, Net Income, Net Financial Position) for FY 2020, discusses business performance, and details significant events that occurred during 2020. This structure—a press release summarizing annual financial results and key operational highlights—is characteristic of an Earnings Release (ER). Although it contains detailed financial figures, its primary function here is the initial announcement of the annual results, rather than being the full, comprehensive Annual Report (10-K) or a detailed Management Discussion and Analysis (MDA). Furthermore, it announces the date for the Shareholders' Meeting, which is often included in such preliminary results announcements. Given the focus on summarizing the year-end results immediately following board approval, ER is the most appropriate classification, although MDA is a close secondary possibility if the text were longer and more analytical. Since it is a press release format announcing the results, ER is preferred over MDA. FY 2020
2021-03-24 Italian
Friulchem: Calendario eventi societari 2021
Report Publication Announcement Classification · 99% confidence The document is titled "CALENDARIO EVENTI SOCIETARI 2021" (Corporate Events Calendar 2021) and lists future dates for key corporate actions, specifically the Board of Directors meeting for approving the 2020 Financial Statements and the Shareholders' Meeting for approving the 2020 Financial Statements. It also mentions the date for the half-year report approval. This document is an announcement detailing the schedule of future corporate events, rather than the actual financial report (10-K or IR) or the results announcement (ER). Since it is an announcement about the timing and schedule of future corporate reports and meetings, it fits best under Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, or potentially Regulatory Filings (RNS) if RPA is too specific. Given the explicit mention of communicating the schedule for financial report approvals, RPA is the most precise fit, as it signals when reports will be released.
2021-01-27 Italian
“WARRANT FRIULCHEM S.P.A. 2019-2022” - ISIN IT0005378366 - CHIUSURA DEL PRIMO PERIODO DI ESERCIZIO 2-30 NOVEMBRE 2020
Share Issue/Capital Change Classification · 99% confidence The document is a press release ("COMUNICATO STAMPA") announcing the conclusion of the first exercise period (November 2-30, 2020) for the company's warrants ("Warrant Friulchem S.p.A. 2019-2022"). It explicitly states that no warrants were exercised during this period and refers readers to the official 'Warrant Regulation' on the company website for more details. This type of announcement, which communicates a specific corporate action or event outcome related to financing instruments (warrants) but is not a comprehensive financial report (like 10-K or IR) or a general regulatory filing (RNS), fits best under Capital/Financing Update (CAP) as it deals directly with the status of outstanding capital instruments. Since it is a specific announcement about financing/capital structure activity, CAP is more precise than the general RNS fallback.
2020-11-30 Italian
Friulchem: riconosciuto credito di imposta su costi di IPO per € 339 mila
Capital/Financing Update Classification · 95% confidence The document is a 'COMUNICATO STAMPA' (Press Release) dated May 8, 2020, announcing that Friulchem S.p.A. received recognition for an IPO Tax Credit ('Credito di Imposta IPO') amounting to approximately EUR 339 thousand from the Ministry of Economic Development. This announcement details a specific financial/regulatory event (tax credit recognition related to capital market activity) but is not a comprehensive annual report (10-K), an interim report (IR), or a formal earnings release (ER) focusing on operational results. It is a specific announcement regarding financing/capital structure implications, making 'Capital/Financing Update' (CAP) the most appropriate category, as it relates directly to costs associated with raising capital (IPO). It is too specific for the general 'Regulatory Filings' (RNS) fallback.
2020-05-08 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.